Evidence map›Paper›PMID 37419554›Full record

ReviewRevista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia

Expert consensus on the integrated diagnosis of idiopathic multicentric Castleman disease.

Santiago Montes-Moreno, Fina Climent, Máximo Fraga, José Luis Patier, Ángel Robles-Marhuenda, Ramón García-Sanz, Enrique M Ocio, Andrés González García, José-Tomás Navarro

Erratum issuedAbstract readReviewConsensus Statement
PubMed Publisher
In one paragraph

Review in Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Santiago Montes-MorenoServicio de Anatomía Patológica y Laboratorio Hematopatología Traslacional, Hospital Universitario Marqués de Valdecilla/IDIVAL, Centro para la Investigación Biomédica CIBERONC, Santander, Spain. Electronic address: santiago.montes@scsalud.es.
Fina ClimentDepartmento de Anatomía Patológica, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Máximo FragaServicio de Anatomía Patológica, Hospital Clínico Universitario de Santiago de Compostela, Departamento Forense, Anatomía Patológica, Ginecología, Obstetricia y Pediatría, Facultad de Medicina de Santiago de Compostela, Spain.
José Luis PatierUnidad de Enfermedades Autoinmune Sistémicas y Minoritarias, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá de Henares, Madrid, Spain.
Ángel Robles-MarhuendaDepartamento de Medicina Interna, Hospital Universitario La Paz, Madrid, Spain.
Ramón García-SanzDepartmento de Hematología, Hospital Universitario de Salamanca, Centro para la Investigación del Cáncer (CiC-IBMCC, CSIC/USAL), Centro para la Investigación Médica CIBERONC, Instituto de Investigación Biomédica de Salamanca (IBSAL), Spain.
Enrique M OcioDepartamento de Hematologia, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
Andrés González GarcíaUnidad de Enfermedades Autoinmune Sistémicas y Minoritarias, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
José-Tomás NavarroLaboratorio de Hematología, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Instituto para la Investigación de la Leucemia Josep Carreras, Spain.
Instituto Ramón y Cajal de Investigación Sanitaria · ESBellvitge University Hospital · ESCentro de Investigación del Cáncer · ESComplejo Hospitalario Universitario de Santiago · ESHospital Universitario La Paz · ESInstitut Català d'Oncologia · ESInstituto de Investigación Marqués de Valdecilla · ESMarqués de Valdecilla University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic multicentric Castleman disease (iMCD) is rare. The differential diagnosis includes inflammatory, autoimmune and neoplastic disease. The identification of the histopathological features of Castleman disease in the lymph node is the main diagnostic criterion. Fifty-three experts from three medical societies (SEMI, SEHH and SEAP) have created a multi-disciplinary consensus document in order to standardise the diagnosis of Castleman disease. Using the Delphi method, specific recommendations for the initial clinical, laboratory and imaging studies have been made for an integrated diagnosis of iMCD as well as for the best way to obtain samples for histopathological confirmation, correct laboratory procedure and interpretation and reporting of results.

Indexed as

Castleman DiseaseDiagnosis, DifferentialHumansDelphi techniqueDiagnosisDiagnósticoDiagnóstico diferencialDifferential diagnosisEnfermedad de Castleman multicéntrica idiopáticaIdiopathic multicentric Castleman diseaseInterleucina-6Interleukin-6Metodología Delphi

Identifiers

PMID37419554
OpenAlexW4319662247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.